RecruitingNCT07189494

European Newborn Study: Early Markers for a Better LifE

ENSEMBLE: European Newborn Study: Early Markers for a Better LifE


Sponsor

dr. M.J.N.L. Benders

Enrollment

1,000 participants

Start Date

Oct 6, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational study is to create a computer model to help doctors predict any problems occurring during development of babies after being diagnosed with brain injury. This will help provide better care to future babies. Next to this, the experiences of parents or caregivers surrounding the first two years after birth of a baby at risk of developing cerebral palsy will be researched to develop recommendations to support parents. Parents of participants will: \- Fill in two online questionnaires, one when their child is 3-4 months corrected age. The second when their child is 2 years corrected age. For the child no additional tests are needed. Only tests that are part of standard clinical practice are performed and are also saved in the study database.


Eligibility

Min Age: 0 YearsMax Age: 2 Years

Inclusion Criteria17

  • All infants with confirmed brain injury on MRI at high risk for CP.
  • Particularly, infants with the following brain injuries at risk for CP will be considered on MRI at term equivalent age or within 10 days after birth or sentinel event:
  • Extensive punctate white matter injury.
  • Periventricular hemorrhagic infarction (any location).
  • Cerebellar injury (ischemic and/or hemorrhages) involving the vermis or involving more than 1/3 of the cerebellar hemisphere and/or lesions involving the cerebellar vermis (Meijler \& Steggerda, 2019).
  • Cystic periventricular leukomalacia (grade 3 \& 4).
  • intraventricular hemorrhages grade III.
  • Posthemorrhagic ventricular dilatation exceeding the 97°percentile + 4mm for the ventricular index (Cizmeci et al., 2020).
  • Perinatal asphyxia with hypoxic ischemic injury of the central gray matter and/or perirolandic area.
  • Perinatal asphyxia with hypoxic ischemic injury in the watershed areas.
  • Perinatal ischemic arterial stroke at high risk for CP, thus with involvement of the corticospinal tracts, cortex, white matter and basal ganglia (Wagenaar et al., 2018).
  • Presence of other brain injuries with expected adverse motor outcome (i.e. big subdural and parenchymal bleedings with/without midline shift, bilirubin induced brain injury) in preterm infants, term infants with neonatal encephalopathy with/without neonatal seizures.
  • Written informed parental consent (Dutch, English, French, German, Italian, Spanish).
  • Any proven or suspected severe congenital anomaly, genetic or metabolic disorder.
  • Presence of an infection of the central nervous system.
  • Parents < 18 years old.
  • Not being able to read one of the six Informed Consent languages.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(8)

Assistance Publique Hôpitaux de Paris

Paris, France

University Hospital Essen

Essen, Germany

Ospedale Pediatrico Meyer Firenze

Florence, Italy

Istituto Giannina Gaslini

Genova, Italy

Ospedale Maggiore di Milano

Milan, Italy

Fondazione Stella Maris

Pisa, Italy

UMC Utrecht

Utrecht, Netherlands

University Hospital La Paz

Madrid, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07189494


Related Trials